Cure cancer from space

Better cancer models. Better drug decisions.

Built for space. Designed for biology.

One platformx to explore cancer biology, generate new insights, and improve drug development.

Product

A new approach to cancer research, built around better evidence.

Better Cancer Models

Investigating tumor biology under microgravity to complement existing preclinical models.

Earlier Insights

Exploring biological evidence that could help identify weak drug candidates sooner.

Built for Biology

Autonomous laboratories engineered around the needs of scientific research.

Combining aerospace engineering, cancer biology, and pharmaceutical research in one platform.

Meet BIOBOX

Our autonomous laboratory platform for cancer research in microgravity.

Why SPARK

Built for space. Designed for scientific discovery.

Scientific Research

Biology comes first.

Our laboratories are developed around defined cancer research questions, experimental controls, and biological measurements.

Space Engineering

From our lab to microgravity.

In just nine months, we engineered and launched BIOBOX-01, demonstrating autonomous cancer research in space and successfully recovering our biological samples.

Features

Our Platform

Cancer Models

Investigating three-dimensional tumor biology.

What’s inside

Breast-cancer spheroids

3D cellular organization

Cell adhesion

Tumor biology

Microgravity Research

Studying cancer under different physical conditions.

What’s inside

Autonomous experiments

Controlled environments

Matched ground controls

Biological sample handling

Drug-Response Studies

Developing methods to compare therapeutic responses.

What’s inside

Candidate evaluation

Comparative experiments

Drug-response measurements

Research reproducibility

Biological Insights

Working toward evidence for better pharmaceutical decisions.

What’s inside

Molecular profiling

Comparative analysis

Biological response data

Future screening applications

We've already taken cancer research into space.

Esrange Space Port

BIOBOX-01

2026

First Mission

9 months

Development to Launch

Pricing

Strong engineering. Serious science.

Two ways to advance cancer research with SPARK.

Scientific
Pharma R&D
Save 30% on a yearly subscription

Scientific

For universities & researchers

1

$38

research mission
fully supported

per month
billed monthly

Hardware access

Joint study design & controls

Sample return

Shared research results

Pharmaceutical

R&D

For oncology and drug discovery

3

$64

year program
co-developed with SPARK

per month
billed monthly

Custom oncology research plan

Comparative response studies

Reproducibility & validation

Candidate-prioritization insights

Frequently asked questions

What does SPARK Microgravity do?

We build small, automated laboratories that study cancer cells in space. Our goal is to develop better cancer models that help pharmaceutical companies understand which treatments are most promising before testing them in patients.

Why study cancer in space?

Because cancer cells can behave differently without Earth's gravity. Research has shown that, under certain conditions, they can grow into three-dimensional structures that share some features with tumors in the human body.

This could help scientists study cancer in new ways and better understand how treatments affect it.

How is SPARK different from traditional cancer research?

Cancer cells are often studied in flat layers in a laboratory. But tumors inside our bodies are three-dimensional and much more complex.

In microgravity, certain cancer cells can form 3D structures that reproduce some features of real tumors. We're investigating whether these models can tell us things that traditional methods might miss.

Have you already sent cancer cells into space?

Yes! In May 2026, we launched our first autonomous laboratory, BIOBOX-01, carrying 3D breast-cancer cell clusters. The experiment operated in space, and we successfully recovered the biological samples. Now we're working toward longer experiments to study how cancer cells respond to different treatments.

How could SPARK help pharmaceutical companies?

Developing cancer treatments is expensive, and many promising drugs fail after years of research. We want to help pharmaceutical companies identify treatments that are less likely to work earlier in development, so they can focus their time and resources on the most promising ones. We're currently developing and testing the research methods needed to make this possible.

Can’t find your answer, contact us.

Explore